Up to $2 million in grant funding may be provided by NIAID to support DARE-HPV development, bringing total non-dilutive funding for DARE-HPV advancement to up to $12 million SAN DIEGO, Feb. 06 ...

Lactiga Secures Multi-Year, Multi-Million Dollar Grant from NIH’s National Institute of Allergy and Infectious Diseases to Advance Groundbreaking, Mucosal-Targeted Secretory IgA for ...

Rep. Paul Gosar (R-AZ), along with 10 other Republican lawmakers, sent a letter to National Institutes of Health Director Jay ...

But even the surviving institutes won’t be spared cuts: The National Institute of Allergy and Infectious Diseases had a budget of more than $6.5 billion in 2025 but will receive just over $4 ...

A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...

A $1,084,824 Phase II Small Business Innovative Research grant from the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health, awarded the funds ...

The National Institutes of Health on Friday announced six acting directors to run institutes, ... and Jeff Taubenberger to run the National Institute of Allergy and Infectious Diseases. ...

A research facility within the US National Institutes of Health that is tasked with studying Ebola and other deadly infectious diseases has been instructed by the Trump administration’s ...

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development.

The content of this press release is solely the responsibility of Daré Bioscience, Inc. and does not necessarily represent the official views of the National Institutes of Health. This press release ...